Use of Bosentan, Theophylline and Vardenafil in Treatment of Priapism

Objective: To evaluate the early therapeutic alternatives such as Bosentan an Endothelin receptor blocker, The­ophylline and Adenosin receptor blocker and Vardenafil a non-selective Phosphodiesterase 5 enzyme inhibitor for the therapy of ischemic priapism in the rat models. Methods: Twenty-four Sprague-Dawley rats were ran­domly divided into 4 equal groups. Control group, Var­denafil group, Bosentan group and Theophylline group. Erection was provided by vacuum constriction method and it was maintained for 4 hours for achieving the pria­pism in all groups. Then, Six rats from each group were sacrificed by cervical dislocation. Consequently, cavern­ous tissue samples were collected and placed in the tis­sue bath. Tissue samples were prepared as 0.5-0.2 cm. strips and put into heat jacketed double walled organ bath containing 37°C krebs solution which is constantly bubbled with 95% O2 and 5 % CO2 and mounted at a resting tension of 1000 mg. After taking the 1 hour record of the three groups except the control group, Bosentan, Theophylline and Vardenafil were admitted in increasing doses. Consequently the alterations of the contractions in the strips due to the drugs and their increasing doses are observed. Results: In this study we detected that Bosentan in­creased the frequency and amplitude of the contractions of the cavernous tissue in the Priapism status in a sta­tistically significant manner, Theophylline decreased the frequency and the amplitude significantly and Vardenafil had statistically no effect on the frequency and amplitude. Conclusion: Inhibition of priapism induced apoptosis with Bosentan, seems promising on preserving erectile function

Technetium Tc 99m sulphur colloid seminal vesicle scintigraphy: A novel approach for the diagnosis of the ejaculatory duct obstruction

OBJECTIVES To define a novel technique in the diagnosis of partial and complete ejaculatory duct obstruction (EDO)